A full time Post-Doctoral research position is available in thelaboratory of Dr. Charles Hong in the Division of Cardiology at theUniversity of Maryland-Baltimore as of June 1, 2018. MD, PhD orMD/PhD scientist is sought to join a laboratory at the forefront ofacademic drug discovery, cardiovascular biology and human inducedpluripotent stem cells (hiPSCs). The Hong laboratory has identifiedsmall molecules that enhance cardiac performance in humanIPSC-derived cardiomyocytes (iPSC-CMs). The first goal is toexamine the mechanism of action of these small molecules byidentifying their cellular targets using cell biological andbiochemical approaches. Second goal is to utilize CRISPR/Cas9genomic engineering technology to examine the impact of genomicablation of the candidate target genes on iPSC-CM and animalmodels.Qualifications :Applicants are required to have a Ph.D. or M.D. and expertise intechniques of cell and molecular biology. Depending on backgroundand interest, the post-doc will perform experiments involvingCRISPR/Cas9 genome editing, proteomics, biochemistry, hiPSCs andiPSC-CMs. Prior experience in these methodologies as well as drugtarget identification and cardiomyocyte physiology are highlyvalued.If interested, please email a CV, a short statement of researchinterests, and the names and contact information for threereferences to Charles Hong, MD, PhD atEmail: [email protected](after June 1, 2018; before that date,[email protected])University of Maryland is an Equal Opportunity Employer encouragingexcellence through diversity. Qualified woman and minoritycandidates are encouraged to apply.